23-30 August 200800
Tt
NPPA Revises CC, PC, PL and
PM Norms
As part of the annual exercise, the National Pharmaceutical Pricing Authority (NPPA) has revised the norms for conversion costs, packaging charges, process loss of materials and packaging material costs, by effecting upto 9 per cent differences.
     
Tt
IPC Prepares 10 more Herbal Monographs to Add in Addendum, 2008
The crude drugs and herbal products committee under the Indian Pharmacopoeia Commission (IPC) has prepared 10 more monographs on herbs and herbal extracts in addition to the 32 herbal monographs included in the Indian Pharmacopoeia 2007 (IP 2007).
     
Tt
Indian States needs more Attention than just Increase in Health Expenditure
The top ten states with Health Expenditure growing at the rate of 25 per cent, have not been able to improve upon the health performance as indicated by their low ranks in indicators such as infant mortality, death rate, availability of health institutions...
     
Tt
Himachal Pradesh:India's
Fastest Growing Pharma Hub
Himachal Pradesh, tucked in the salubrious climes of the Himalayan mountain range, offers the most ideal and the fastest growing destination for Indian pharmaceutical industry, thanks to the State's Industrial Policy that has boosted...
     
Tt
OIMBL Launches New
MRI Technology
OIMBL's PharmaSense is a versatile MRI tool that allows drug makers to assess tablet dynamics and potentially improve API delivery. UK-based Oxford Instruments Molecular Biotool's (OIMBL) technology is the first commercially-available...
     
Tt
Anemia: Symptoms, Causes
and Prevention
Anemia isn't a disease in itself, but a result of a malfunction somewhere in the body. This blood condition is common, particularly in females. Some estimates suggest that around one in five menstruating women and half of all pregnant women are anemic.
     
Tt
Centre Mulls Over Special Drug
Stores for Poor
The government plans to launch special drug stores that will sell generic medicines as part of its efforts to provide affordable medicines to poorer sections of the society. The idea to provide cheaper but good-quality medicines to less privileged is...
     
Tt
U.S. FDA Approves Amgen's Blood
Platelet Booster
Amgen Inc drug Nplate is safe and effective for treating a rare clotting disorder that can cause dangerous bleeding, the Food and Drug Administration said on Friday in approving the product for U.S. sales.The injectable drug helps stimulate bone marrow into producing blood platelets in patients with chronic immune...
  Celgene Wins FDA Approval to
Expand Vidaza Label
 
Celgene has announced that Vidaza has received expanded FDA approval to reflect new overall survival achieved in the AZA-001 survival study of patients with higher-risk myelodysplastic syndromes. This expanded indication supplements the 2004 FDA authorization of Vidaza...
   
  Aurobindo Pharma gets Initial US nod
for Losartan Tabs
 
Aurobindo Pharma Ltd received a tentative approval from the U.S. Food and Drug Administration for its generic losartan potassium tablets in multiple strengths. The drug is the generic equivalent of Merck & Co Inc's (MRK.N: Quote, Profile, Research) anti-hypertensive...
   
     
Tt
NANOTECHNOLOGY: The Science
of the Future
Federation of Indian Chambers of Commerce and Industry (FICCI), in partnership with Ministry of Science and Technology is organizes India R & D Conferences, on annual basis. The first Conference in the Series "India R & D 2008: Nanotechnology - The Science of the Future" is scheduled on September 5, 2008 at...
     
• Expect inflation to go down albeit slowly to 7% by March-end.
• Inflation to move from 4-6% to 6-8% band for the next few years.
• Oil cools to early-June levels – volatility to continue.
• Cereal prices to go down, great monsoons in north and east.
 
 
 
 
 
 
 
 
 
 
 
Our Pharmaquest Portal
 
 
 
Readers can contribute Articles, Reports, Case Studies, Success Stories, Advertorials besides formal Advertisements.
Disclaimer: Since India has no anti-spamming law, we follow the US directive passed in Bill.1618 Title III by the 105th US Congress, which states that mail cannot be considered spam if it contains contact information, which this mail does. This mail is not a Spam Mail. In case you do not wish to receive mails (unsubscribe), kindly send a mail to susheela@newmediacomm.biz